Urinary Activin A is a novel biomarker reflecting renal inflammation and tubular damage in ANCA-associated vasculitis.

Urinary Activin A is a novel biomarker reflecting renal inflammation and tubular damage in ANCA-associated vasculitis.

Activin A, a member of the transforming growth factor-beta superfamily, is a critical modulator of inflammation and plays a key role in controlling the cytokine cascade that drives the inflammatory response. However, the role of activin A in inflammatory kidney diseases remains unknown. To address t...

Full description

Bibliographic Details
Main Authors:	Yoshinori Takei, Shunsuke Takahashi, Masao Nakasatomi, Toru Sakairi, Hidekazu Ikeuchi, Yoriaki Kaneko, Keiju Hiromura, Yoshihisa Nojima, Akito Maeshima
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2019-01-01
Series:	PLoS ONE
Online Access:	https://doi.org/10.1371/journal.pone.0223703

Similar Items

Enhancement of HGF-induced tubulogenesis by endothelial cell-derived GDNF.
by: Masao Nakasatomi, et al.
Published: (2019-01-01)

Attenuation of renal fibrosis after unilateral ureteral obstruction in mice lacking the N-type calcium channel.
by: Keiichiro Mishima, et al.
Published: (2019-01-01)

Follistatin, an Activin Antagonist, Ameliorates Renal Interstitial Fibrosis in a Rat Model of Unilateral Ureteral Obstruction
by: Akito Maeshima, et al.
Published: (2014-01-01)

Hepatitis E during Tocilizumab Therapy in a Patient with Rheumatoid Arthritis: Case Report and Literature Review
by: Hidekazu Ikeuchi, et al.
Published: (2018-01-01)

Diverse Cell Populations Involved in Regeneration of Renal Tubular Epithelium following Acute Kidney Injury
by: Akito Maeshima, et al.
Published: (2015-01-01)

Importance of methodology in the evaluation of renal mononuclear phagocytes and analysis of a model of experimental nephritis with Shp1 conditional knockout mice
by: Mitsuharu Watanabe, et al.
Published: (2020-07-01)

Regenerative Medicine for the Kidney: Renotropic Factors, Renal Stem/Progenitor Cells, and Stem Cell Therapy
by: Akito Maeshima, et al.
Published: (2014-01-01)

Immunopathogenesis of ANCA-Associated Vasculitis
by: Andreas Kronbichler, et al.
Published: (2020-10-01)

Epidemiology of ANCA associated vasculitis
by: Wenche Koldingsnes, et al.
Published: (2008-01-01)

ANCA-Associated Vasculitis: An Update
by: Salem Almaani, et al.
Published: (2021-04-01)

Personalized Medicine in ANCA-Associated Vasculitis ANCA Specificity as the Guide?
by: Zachary S. Wallace, et al.
Published: (2019-12-01)

ANCA-positive vasculitis: Clinical implications of ANCA types and titers
by: Vital Manuel Da Silva Domingues, et al.

Animal Models of ANCA Associated Vasculitis
by: Lani Shochet, et al.
Published: (2020-04-01)

Individualization of the ANCA associated vasculitis treatment
by: Zbigniew Zdrojewski
Published: (2014-09-01)

Treatment of Renal ANCA-associated Vasculitis
by: Mafalda Teixeira da Costa
Published: (2021)

Granulomatous Inflammation in ANCA-Associated Vasculitis
by: Antje Müller, et al.
Published: (2021-06-01)

Interstitial Lung Disease with ANCA-associated Vasculitis
by: Yasuhiro Katsumata, et al.
Published: (2015-01-01)

Interstitial Lung Disease with ANCA-associated Vasculitis
by: Yasuhiro Katsumata, et al.
Published: (2015-09-01)

ANCA-associated vasculitis in childhood: recent advances
by: Marta Calatroni, et al.
Published: (2017-05-01)

Why are patients with ANCA-associated vasculitis fatigued?
by: McClean, Andrew
Published: (2016)

Biological therapy in the treatment of ANCA associated vasculitis
by: Smith, Rona Marie
Published: (2016)

Autoreactive B Cells in ANCA-Associated Vasculitis
by: Berti, Alvise
Published: (2021)

RECURRENT ANCA-ASSOCIATED VASCULITIS AFTER KIDNEY ALLOTRANSPLANTATION
by: N. F. Frolova, et al.
Published: (2016-03-01)

The Pathogenicity of BPI-ANCA in a Patient With Systemic Vasculitis
by: Sayo Takeda, et al.
Published: (2019-06-01)

Long- term outcome of paediatric patients with ANCA vasculitis
by: Pusey Charles D, et al.
Published: (2011-06-01)

Pathogenesis and Diagnosis of Otitis Media with ANCA-Associated Vasculitis
by: Naohiro Yoshida, et al.
Published: (2014-01-01)

Is rituximab effective for induction of remission in ANCA-associated vasculitis?
by: Carmen Rain, et al.
Published: (2015-08-01)

Endothelial dysfunction of vessels at ANCA-associated systemic vasculitis
by: L. V. Sedaia, et al.
Published: (2015-08-01)

Pauci-Immune Crescentic Glomerulonephritis: An ANCA-Associated Vasculitis
by: Rafeel Syed, et al.
Published: (2015-01-01)

GENETIC SUSCEPTIBILITY TO ANCA-ASSOCIATED VASCULITIS: STATE OF THE ART
by: Francesco eBonatti, et al.
Published: (2014-11-01)

Clinical features and outcomes of ANCA-associated renal vasculitis
by: Sidy Mohamed Seck, et al.
Published: (2012-01-01)

Methimazole-Induced ANCA Vasculitis: A Case Report
by: Precil Diego Miranda de Menezes Neves, et al.
Published: (2021-08-01)

The Contribution of Innate Immunity to the Pathogenesis of ANCA-associated Vasculitis
by: Söderberg, Daniel
Published: (2016)

Dissecting mechanisms of granuloma formation in ANCA-associated vasculitis
by: Henderson, Scott Russell
Published: (2018)

Hematoma intraparenquimatoso asociado a vasculitis ANCA positiva
by: Patricia Puerta Roldán, et al.
Published: (2020-02-01)

ANCA - associated renal vasculitis - epidemiology, diagnostics and treatment
by: Říhová, Zuzana
Published: (2006)

Circulating B Cells, Plasma Cells, and Treg Associate with ANCA Levels in ANCA-associated Vasculitis
by: Joaquin Manrique, et al.
Published: (2021-02-01)

PROBLEMS IN THE DIAGNOSIS AND TREATMENT OF ANCA-ASSOCIATED SYSTEMIC VASCULITIS: IN THE FOCUS OF ANCA-NEGATIVE PAUCI-IMMUNE GLOMERULONEPHRITIS
by: T. V. Beketova, et al.
Published: (2016-12-01)

New concepts in ANCA detection and disease classification in small vessel vasculitis: the role of ANCA antigen specificity
by: Elena Csernok
Published: (2018-01-01)

A Case of Crescentic Glomerulonephritis Complicated with Hypocomplementemic Urticarial Vasculitis Syndrome and ANCA-Associated Vasculitis
by: Marenao Tanaka, et al.
Published: (2017-11-01)